Gelmann EP - Search Results

1

Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer.

Branigan GL, Torrandell-Haro G, Soto M, Gelmann EP, Vitali F, Rodgers KE, Brinton RD. Branigan GL, et al. Among authors: gelmann ep. Cancer Med. 2022 Jul;11(13):2687-2698. doi: 10.1002/cam4.4650. Epub 2022 Mar 16. Cancer Med. 2022. PMID: 35293700 Free PMC article.

2

The expanding role of hormones in cancer.

Gelmann EP. Gelmann EP. Endocr Oncol. 2021 Feb 4;1(1):E1-E2. doi: 10.1530/EO-21-0001. eCollection 2021 Jan. Endocr Oncol. 2021. PMID: 37435183 Free PMC article. No abstract available.

3

CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss.

Bowen C, Shibata M, Zhang H, Bergren SK, Shen MM, Gelmann EP. Bowen C, et al. Among authors: gelmann ep. Cancer Res. 2020 Nov 1;80(21):4805-4814. doi: 10.1158/0008-5472.CAN-20-1742. Epub 2020 Sep 17. Cancer Res. 2020. PMID: 32943441 Free PMC article.

4

Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.

Bowen C, Ostrowski MC, Leone G, Gelmann EP. Bowen C, et al. Among authors: gelmann ep. Cancer Res. 2019 Aug 15;79(16):4124-4134. doi: 10.1158/0008-5472.CAN-18-4110. Epub 2019 Jun 18. Cancer Res. 2019. PMID: 31213464 Free PMC article.

5

Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.

Leighton X, Bera A, Eidelman O, Bubendorf L, Zellweger T, Banerjee J, Gelmann EP, Pollard HB, Srivastava M. Leighton X, et al. Among authors: gelmann ep. PLoS One. 2018 Oct 15;13(10):e0205837. doi: 10.1371/journal.pone.0205837. eCollection 2018. PLoS One. 2018. PMID: 30321230 Free PMC article.

6

Nkx3.1 controls the DNA repair response in the mouse prostate.

Zhang H, Zheng T, Chua CW, Shen M, Gelmann EP. Zhang H, et al. Among authors: gelmann ep. Prostate. 2016 Mar;76(4):402-8. doi: 10.1002/pros.23131. Epub 2015 Dec 10. Prostate. 2016. PMID: 26660523 Free PMC article.

7

Treatment of the Prostate in the Presence of Metastases: Lessons from Other Solid Tumors.

Neugut AI, Gelmann EP. Neugut AI, et al. Among authors: gelmann ep. Eur Urol. 2016 May;69(5):795-6. doi: 10.1016/j.eururo.2015.06.004. Epub 2015 Jun 19. Eur Urol. 2016. PMID: 26099904 No abstract available.

8

NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage.

Bowen C, Zheng T, Gelmann EP. Bowen C, et al. Among authors: gelmann ep. Cancer Res. 2015 Jul 1;75(13):2686-98. doi: 10.1158/0008-5472.CAN-14-3387. Epub 2015 May 14. Cancer Res. 2015. PMID: 25977336 Free PMC article.

9

The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.

Song LN, Silva J, Koller A, Rosenthal A, Chen EI, Gelmann EP. Song LN, et al. Among authors: gelmann ep. Mol Cancer Res. 2015 May;13(5):913-22. doi: 10.1158/1541-7786.MCR-14-0680. Epub 2015 Mar 16. Mol Cancer Res. 2015. PMID: 25777618 Free PMC article.

10

Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate Cancer.

Muhlbradt E, Ma J, Severi G, Ortner E, Hayes V, Hoang HN, Stampfer M, Giles G, Pollak M, Gelmann EP. Muhlbradt E, et al. Among authors: gelmann ep. Genes Cancer. 2013 Nov;4(11-12):535-45. doi: 10.1177/1947601913506009. Genes Cancer. 2013. PMID: 24386513 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page